HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Alba A Brandes Selected Research
Alba A Brandes Research Topics
Disease
62
Glioblastoma (Glioblastoma Multiforme)
10/2023 - 01/2002
58
Neoplasms (Cancer)
10/2023 - 05/2002
25
Glioma (Gliomas)
01/2021 - 05/2002
17
Disease Progression
01/2020 - 02/2003
14
Brain Neoplasms (Brain Tumor)
10/2022 - 05/2002
9
Oligodendroglioma
01/2019 - 06/2006
8
Astrocytoma (Pilocytic Astrocytoma)
03/2024 - 12/2003
8
Breast Neoplasms (Breast Cancer)
11/2020 - 09/2004
7
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 05/2009
6
Medulloblastoma
12/2019 - 10/2003
3
Cognitive Dysfunction
01/2019 - 05/2004
3
Neoplasm Metastasis (Metastasis)
09/2017 - 10/2004
2
Thrombocytopenia (Thrombopenia)
01/2023 - 09/2014
2
Lymphopenia (Lymphocytopenia)
01/2021 - 09/2014
2
Vomiting
01/2020 - 12/2007
2
Nausea
01/2020 - 12/2007
2
Necrosis
11/2019 - 11/2013
2
Adenocarcinoma of Lung
01/2017 - 01/2017
2
Fatigue
11/2016 - 05/2015
2
Colorectal Neoplasms (Colorectal Cancer)
05/2016 - 05/2014
2
Neutropenia
05/2015 - 09/2014
2
Lymphoma (Lymphomas)
04/2014 - 10/2009
1
Central Nervous System Neoplasms
01/2022
1
Adenoma (Adenomas)
01/2022
1
Pituitary Neoplasms (Pituitary Adenoma)
01/2022
1
Meningioma (Meningiomas)
01/2021
1
Seizures (Absence Seizure)
08/2020
1
Epilepsy (Aura)
08/2020
1
Head and Neck Neoplasms (Head and Neck Cancer)
12/2017
1
Primary Ovarian Insufficiency
05/2017
1
Infertility (Sterility)
05/2017
1
Infections
11/2016
Drug/Important Bio-Agent (IBA)
49
Temozolomide (Temodar)
FDA Link
Generic
03/2024 - 01/2002
21
Bevacizumab (Avastin)
FDA Link
10/2023 - 10/2009
20
Lomustine (CCNU)
FDA Link
10/2023 - 02/2003
12
Procarbazine (Matulane)
FDA Link
10/2022 - 01/2002
12
Vincristine (Oncovin)
FDA Link
Generic
10/2022 - 01/2002
10
Biomarkers (Surrogate Marker)
IBA
10/2023 - 10/2003
8
Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))
IBA
10/2023 - 11/2013
6
Trastuzumab (Herceptin)
FDA Link
11/2020 - 08/2007
6
Methyltransferases
IBA
04/2018 - 10/2006
5
ErbB Receptors (EGF Receptor)
IBA
01/2017 - 02/2008
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
06/2014 - 02/2007
4
Nivolumab
IBA
01/2023 - 12/2017
3
Hormones (Hormone)
IBA
11/2020 - 09/2004
3
Monoclonal Antibodies
IBA
09/2017 - 12/2009
3
Angiogenesis Inhibitors
IBA
08/2017 - 05/2011
3
DNA (Deoxyribonucleic Acid)
IBA
10/2016 - 10/2006
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
10/2014 - 03/2009
2
pembrolizumab
IBA
01/2022 - 12/2017
2
Immune Checkpoint Inhibitors
IBA
01/2022 - 01/2020
2
MicroRNAs (MicroRNA)
IBA
11/2021 - 11/2015
2
taxane
IBA
11/2020 - 06/2015
2
Platinum
IBA
12/2017 - 05/2015
2
LY-2157299
IBA
05/2017 - 01/2016
2
Transforming Growth Factors (Transforming Growth Factor)
IBA
05/2017 - 01/2016
2
Phosphotransferases (Kinase)
IBA
05/2017 - 01/2016
2
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
01/2017 - 02/2007
2
Tyrosine Kinase Inhibitors
IBA
01/2017 - 02/2010
2
fotemustine (Muphoran)
IBA
01/2016 - 09/2009
2
Lapatinib (GW572016)
FDA Link
11/2013 - 02/2010
2
O-(6)-methylguanine
IBA
03/2010 - 10/2006
2
Carmustine (FIVB)
FDA Link
03/2009 - 12/2004
2
Imatinib Mesylate (Gleevec)
FDA Link
10/2008 - 12/2003
2
Cisplatin (Platino)
FDA Link
Generic
07/2005 - 05/2004
2
thiamine triphosphorate (TTP)
IBA
02/2003 - 01/2002
1
RNA (Ribonucleic Acid)
IBA
03/2024
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2023
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
08/2022
1
Ipilimumab
IBA
01/2022
1
Messenger RNA (mRNA)
IBA
01/2022
1
Matrix Metalloproteinase 2 (Gelatinase A)
IBA
01/2022
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
01/2022
1
Growth Hormone (Somatotropin)
IBA
01/2022
1
Contrast Media
IBA
12/2021
1
Gadolinium
IBA
12/2021
1
regorafenib
IBA
01/2021
1
Anthracyclines
IBA
11/2020
1
Biological Factors
IBA
11/2019
1
Indicators and Reagents (Reagents)
IBA
01/2019
1
human ERBB2 protein
IBA
12/2018
1
Genetic Markers (Genetic Marker)
IBA
01/2018
1
Codon (Codons)
IBA
01/2018
1
Antibodies
IBA
12/2017
1
sonidegib
IBA
10/2017
1
Glial Fibrillary Acidic Protein
IBA
05/2017
1
Chemokine CCL22
IBA
05/2017
1
Ligands
IBA
01/2017
1
onartuzumab
IBA
01/2017
1
Gefitinib (Iressa)
FDA Link
01/2017
Therapy/Procedure
51
Radiotherapy
01/2023 - 01/2002
48
Drug Therapy (Chemotherapy)
01/2023 - 05/2002
31
Therapeutics
11/2020 - 05/2002
5
Chemoradiotherapy
01/2020 - 05/2008
4
Adjuvant Chemotherapy
12/2007 - 02/2003
3
Immunotherapy
12/2017 - 11/2015
3
Salvage Therapy
09/2009 - 07/2005
2
Adjuvant Radiotherapy
01/2021 - 03/2005
2
Aftercare (After-Treatment)
01/2020 - 12/2007
1
Drug Tapering
01/2023